Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies

Recombinant Cryptosporidium parvum GP15 based enzyme linked immunosorbent assay for detection of exposure of bovine populations to Cryptosporidium

The serodiagnostic potential of recombinant Cryptosporidium parvum glycoprotein 15 (rCpGP15) was evaluated in Enzyme Linked Immunosorbent Assay (ELISA) in the detection of exposure of bovines to Cryptosporidium species in Himachal Pradesh and Uttarakhand states of North India. The 11.13 kDa rCpGP15 was expressed in pET-32a (+) transformed E. coli BL21 cells and was purified by Ni-NTA affinity chromatography as polyhistidine tagged fusion protein of ∼ 32 kDa. Its immunogenicity was checked in western blot using rabbit antisera raised to the recombinant antigen and bovine sera naturally infected with Cryptosporidium. Two hundred and forty-six bovines were screened for Cryptosporidium spp. oocysts in faecal samples by modified-Ziehl Neelson technique and their sera were used for ELISA standardization. The rCpGP15 based indirect IgG-ELISA was standardized with 83 % sensitivity, 78.3 % specificity where ELISA cut-off and accuracy were decided using ROC curve analysis. The percent accuracy was 79.19 %, with area under the Receiver Operating Characteristic (ROC) curve value 0.827 depicting the moderate accuracy of the assay. Additionally, sera from Eimeria (n = 3), strongyles (n = 3), Babesia (n = 2), Theileria (n = 5), Trypanosoma (n = 2) and Anaplasma (n = 5) positive animals showed no seroreactivity. The diagnostic performance of rCpGP15 protein in differentiating Cryptosporidium species was predicted through in-silico B cell epitope prediction, homology modelling and structural comparison of GP15 protein from C. parvum, C. hominis, C. bovis and C. ryanae. Four linear antigenic epitopes were predicted in CpGP15 protein sequence by SVMTrip. The overall root mean square deviation (RMSD) values during homology modelling and structural comparison of CpGP15 and C. hominis, C. bovis and partial C. ryanae GP15 were 2.093 Å, 3.759 Å and 1.152 Å, respectively. The serodiagnostic assay developed in the present study has moderate accuracy and can be applied in serosurveillance of large bovine populations. It is capable of detecting asymptomatic animals with intermittent oocyst shedding which will further be helpful for better understanding the disease dynamics and for the timely control of cryptosporidiosis.

Use of Recombinant CP2 and CP23 Antigens of Cryptosporidium parvum for Serodiagnosis of Human Cryptosporidiosis

Background

Cryptosporidium parvum is an important coccidian parasite infecting many mammals, including human. This parasite can manifest as chronic severe diarrhea in immunocompromised individuals, especially those with AIDS. The present study reports the recombinant production of recombinant (r)P2 and rP23 antigens of C. parvum as antigens for detecting human cryptosporidiosis using indirect ELISA tests.

Methods

The coding sequences of rP2 and rP23 proteins were codon-optimized, commercially synthesized and sub-cloned in the pET28a expression vector. The expressed proteins were purified by Ni-NTA column chromatography and confirmed by Western blotting. The efficacy of rP2/rP23 proteins for serodiagnosis was evaluated by positive (n = 20) and negative (n = 20) human sera, confirmed by the Ziehl-Neelsen staining as the gold standard test.

Results

In ELISA test, the sera from C. parvum-infected patients reacted strongly to rP2/rP23. The sensitivity and specificity related to the diagnostic potential of rP2/rP23 in the ELISA assay were 100%.

Conclusion

Our results showed that combination of rP23 and rP2 antigens in ELISA significantly increases the performance of C. parvum serodiagnosis in human cryptosporidiosis.

Recombinant Expression And Indirect ELISA For COWP And HSP70 Proteins From Cryptosporidium andersoni

Cryptosporidium spp. infect cattle at a high rates, and reduce milk production. Cryptosporidiosis has caused economic losses for the dairy industry. Studies in Western countries have shown that Cryptosporidium can also infect humans. Therefore, the development of methods for the early detection of Cryptosporidium is an important public health objective. Total RNA isolated from C. andersoni was used as template for generating cDNA encoding the COWP and HSP70 proteins. The recombinant plasmid, pET-32a(+)-COWP-HSP70, was constructed by double digestion and subcloning. The expression of the three recombinant proteins was induced in Escherichia coli BL21 using isopropyl-β-D-thiogalactopyranoside. The antigenicity of the recombinant proteins was examined using western blotting and indirect ELISA. The identities of the COWP fusion protein (CFP), HSP70 fusion protein (HFP), and COWP-HSP70 fusion protein (CHFP) were confirmed by BLAST searches of known sequences in GenBank respectively. The ELISA and western blot analyses indicated that all three of the proteins were highly immunogenic and antigenic. An indirect ELISA method was developed using the three recombinant proteins as coating antigens for the analysis of 40 clinical samples. The results showed that CHFP was the best candidate antigen for clinical testing, with a detection rate of 100%, compared with general parasitological screening. Above of all, the recombinant CHFP protein represents the best candidate antigen among three ones for detecting anti-Cryptosporidium antibodies in clinical samples. The development of the indirect ELISA lays the foundation for further research in immunodiagnosis and disease prevention of cryptosporidiosis.

Laboratory diagnosis of cryptosporidiosis

Cryptosporidiosis is a major etiology of persistent and chronic diarrhea in children and immunocompromised patients. In addition, it is also one of the important pathogens causing zoonotic or waterborne outbreaks. A number of conventional and molecular tests are available, but each test is riddled with few limitations. Further, there is a need to develop point of care tests and multiplexed tests for simultaneous detection of multiple pathogens.

Prevalence of Cryptosporidium spp. in ruminants of Lorestan province, Iran

Cryptosporidiosis is one of the important zoonotic diseases caused by an intracellular protozoan parasite called Cryptosporidium. This study aimed to investigate the prevalence of Cryptosporidium spp. infection on 1,115 ruminants, cattle, sheep and goats, in Lorestan province, Iran. Using formol-ether concentration technique and modified Ziehl-Neelsen staining method afterwards, the overall prevalence of Cryptosporidium spp. infection in ruminants of Lorestan province was 7.17 %. Prevalence of infection was 9.07 % (39 of 430), 5.80 % (20 of 345) and 6.18 % (21 of 340) for cattle, sheep and goats respectively. There was no significant difference between contamination of all examined animals and different geographical and climatic situations (P > 0.05) and diarrhea was not directly associated with Cryptosporidium infection (P > 0.05). In conclusion, the prevalence of cryptosporidiosis in Lorestan province was relatively low, but it should be noticed that this opportunistic parasite is zoonosis and also can make epidemics in ruminants as well as human population in suitable conditions.

First molecular characterization ofCryptosporidiumin Yemen

Cryptosporidiumis a protozoan parasite of humans and animals and has a worldwide distribution. The parasite has a unique epidemiology in Middle Eastern countries where the IId subtype family ofCryptosporidium parvumdominates. However, there has been no information onCryptosporidiumspecies in Yemen. Thus, this study was conducted in Yemen to examine the distribution ofCryptosporidiumspecies and subtype families. Fecal samples were collected from 335 patients who attended hospitals in Sana'a city.Cryptosporidiumspecies were determined by PCR and sequence analysis of the 18 s rRNA gene.Cryptosporidium parvumandC. hominissubtypes were identified based on sequence analysis of the 60 kDa glycoprotein (gp60) gene. Out of 335 samples, 33 (9·9%) were positive forCryptosporidium. Of them, 97% were identified asC. parvumwhilst 1 case (3%) was caused byC. hominis. All 7C. parvumisolates subtyped belonged to the IIaA15G2R1 subtype. The common occurrence of the zoonotic IIa subtype family ofC. parvumhighlights the potential occurrence of zoonotic transmission of cryptosporidiosis in Yemen. However, this postulation needs confirmation with future molecular epidemiological studies of cryptosporidiosis in both humans and animals in Yemen.

Simultaneous detection of serum immunoglobulin G antibodies to Cryptosporidium parvum by multiplex microbead immunoassay using 3 recognized specific recombinant C. parvum antigens

Cryptosporidiosis is a significant diarrheal disease in both humans and other mammals worldwide. In the present study, we established and validated a multiplex microbead immunoassay (MIA) for surveillance of Cryptosporidium parvum infections. In the multiplex MIA, 3 specific recombinant proteins, CP23, SA35, and SA40, were used as the capture antigens simultaneously. The antibody directed against CP23 is an index of historic infection, and those against SA35 and SA40 are indices of recent infection. The multiplex MIA yielded essentially identical results with that of monoplex MIA using these 3 recombinant proteins, and the reproducibility of the multiplex MIA results was high when standardized with a calibration curve. With multiplex MIA, we detected that the pediatric population showed a higher percentage of recent infections (seropositive rates of antibodies directed against CP23, SA35, and SA40 were 6.28%, 23.19%, and 22.71%, respectively, n = 207), whereas the adult population showed a higher percentage of historic infections (seropositive rates of antibodies directed against CP23, SA35, and SA40 were 24.40%, 11.48%, and 16.75%, respectively, n = 209).

Molecular cloning, expression and first antigenic characterization of human astrovirus VP26 structural protein and a C-terminal deleted form

The open reading frame 2 (ORF2) of human astrovirus (HAstV) encodes the structural VP26 protein that seems to be the main antigenic viral protein. However, its functional role remains unclear. Bioinformatic predictions revealed that VP29 and VP26 proteins could be involved in virus-cell interaction. In this study, we describe for the first time the cloning and expression in Escherichia coli (E. coli) of a recombinant VP26 (rVP26) protein and a VP26 C-terminal truncated form (VP26 Delta C), followed by purification by NTA-Ni(2+) agarose affinity chromatography. Protein expression and purification were evaluated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot (WB). Then, the purified proteins were evaluated for antigenic properties in enzyme linked immunosorbent assay (ELISA) using a polyclonal antibody (PAb) and a neutralizing monoclonal antibody (nMAb) named PL2, both of them directed to HAstV. The results presented herein indicate that the C-terminal end of the VP26 protein is essential to maintain the neutralizing epitope recognized by nMAb PL2 and that the N-terminus of VP26 protein may contain antigenic lineal-epitopes recognized by PAb. Thus, these recombinant proteins can be ideal tools for further antigenic, biochemical, structural and functional VP26 protein characterization, in order to evaluate its potential role in immunodiagnosis and vaccine studies.

Molecular targets for detection and immunotherapy in Cryptosporidium parvum

Cryptosporidium parvum is an obligate protozoan parasite responsible for the diarrheal illness cryptosporidiosis in humans and animals. Although C. parvum is particularly pathogenic in immunocompromised hosts, the molecular mechanisms by which C. parvum invades the host epithelial cells are not well understood. Characterization of molecular-based antigenic targets of C. parvum is required to improve the specificity of detection, viability assessments, and immunotherapy (treatment). A number of zoite surface (glyco)proteins are known to be expressed during, and believed to be involved in, invasion and infection of host epithelial cells. In the absence of protective treatments for this illness, antibodies targeted against these zoite surface (glyco)proteins offers a rational approach to therapy. Monoclonal, polyclonal and recombinant antibodies represent useful immunotherapeutic means of combating infection, especially when highly immunogenic C. parvum antigens are utilized as targets. Interruption of life cycle stages of this parasite via antibodies that target critical surface-exposed proteins can potentially decrease the severity of disease symptoms and subsequent re-infection of host tissues. In addition, development of vaccines to this parasite based on the same antigens may be a valuable means of preventing infection. This paper describes many of the zoite surface glycoproteins potentially involved in infection, as well as summarizes many of the immunotherapeutic studies completed to date. The identification and characterization of antibodies that bind to C. parvum-specific cell surface antigens of the oocyst and sporozoite will allow researchers to fully realize the potential of molecular-based immunotherapy to this parasite.